NCT03668314View on ClinicalTrials.gov

Single and Multiple Ascending Dose and Food Effect PK Study in Healthy Adult and Elderly Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

October 10, 2018

Primary Completion Date

April 15, 2019

Study Completion Date

April 15, 2019

Conditions
Healthy
Interventions
DRUG

RDN-929

Single dose from 2 mg to TBD

DRUG

Placebo oral capsule

Matching placebo Single dose

DRUG

RDN-929 TBD dose

Fed vs fast dose TBD based upon results of previous cohorts

DRUG

RDN-929

Multiple dose based on results of previous cohorts

DRUG

Placebo oral capsule

Matching placebo multiple dose

Trial Locations (1)

Unknown

QPS Netherlands B.V., Groningen

Sponsors

Lead Sponsor

Alkermes, Inc.
All Listed Sponsors
collaborator

QPS Netherlands B.V.

INDUSTRY

lead

Alkermes, Inc.

INDUSTRY

NCT03668314 - Single and Multiple Ascending Dose and Food Effect PK Study in Healthy Adult and Elderly Subjects | Biotech Hunter | Biotech Hunter